Broad Agency Announcements for Advanced Research and Development of Medical Countermeasures...
New initiative supporting the advanced development of influenza vaccine candidates with the goal to provide enhanced, long-lasting protection from a broad range of antigenically divergent influenza viruses within and across subtypes.
The 2014 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy and Implementation Plan (SIP)
The 2014 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy and Implementation Plan (SIP) describes the priorities that HHS, in collaboration with its interagency partners, will implement over the next five years.more announcements
HHS Centers for Innovation in Advanced Development and Manufacturing
- A Justification for Other than Full and Open Competition (JOFOC) for the use of Vaxin to solicit: "A new Request for Task Order Response (RTOR) for the continued development Vaxin's Ad5 Vectored Anthrax vaccine candidate via the HHS CIADM program."
- A Justification for Other than Full and Open Competition for the use of Pfenex Inc. to solicit: "A new RTOR for the continued development of the Pfenex Expression Technology™ for an anthrax vaccine via the HHS CIADM program"
- Webcast Announcement: HHS creates new centers to develop, manufacture medical countermeasures
- HHS Creates New Centers